Ihlatshwe yigagasi lesihlanu ledolobha le-COVID-19, iHong Kong ibhekene nesikhathi sayo sezempilo esibi kakhulu selokhu kwaqala lolu bhubhane eminyakeni emibili edlule.Kuphoqe uhulumeni wedolobha ukuthi enze izinyathelo eziqinile, okubandakanya nokuhlolwa okuyimpoqo kuzo zonke izakhamizi zaseHong Kong.
NgoFebhuwari ubone izinkulungwane zamacala amasha, ikakhulukazi avela kokuhlukile kwe-omicron.Okuhlukile kwe-Omicron kusabalala kalula kunegciwane lokuqala elibangela i-COVID-19 kanye nokwehlukile kwe-Delta.I-CDC yayilindele ukuthi noma ubani onokutheleleka nge-Omicron angasakaza leli gciwane kwabanye, ngisho noma begonyiwe noma bengenazo izimpawu.
Ngokwezibalo ezibuyekeziwe, amanye amacala aqinisekisiwe angama-29272 abikwa ngoMashi 16 avela eSikhungweni Sokuvikelwa Kwezempilo (CHP) soMnyango Wezempilo (DH), eHong Kong.Ngenxa yamacala amaningi aqinisekisiwe nsuku zonke, igagasi lakamuva lokutheleleka kwe-COVID-19 "likhungathekile" iHong Kong, umholi wedolobha uyaxolisa ukusho.Izibhedlela zazishoda ngemibhede futhi kunzima ukubhekana nazo, futhi abantu baseHongkong babethukile.Ukuze kwehliswe amacala aqinisekisiwe futhi kudambise ingcindezi, kwakudingeka inani elikhulu lamakhithi okuhlola ukuze kuhlolwe abantu abaningi.Nokho, ngenxa yezidingo ezikhulayo, bezingekho izimpahla ezanele esitokweni.Ngemva kokufunda ngalesi simo, i-Bioantibody Biotechnology Co., Ltd. (Bioantibody) yangena ngokushesha esimweni "sokulungiselela impi".Abantu be-Bioantibody basebenze kanzima ukuze bakhiqize izinto zokusetshenziswa ezibalulekile kanye namakhithi okuhlola asheshayo e-SARS-CoV-2 antigen aqediwe.Ngokubambisana nezinhlaka zikahulumeni kanye nenhlangano yamaShayina aphesheya kwezilwandle evela e-Yixing naseShanwei, i-Bioantibody ilethe inani elikhulu lamathuluzi e-Hong Kong.U-Bioantibody ufise ukuthi lezi zinsiza zingabamba iqhaza ekuxazululeni izidingo eziphuthumayo zabahlali base-Hong Kong futhi wenze lokho i-Bioantibody engakwenza ekunqandeni ubhubhane.
I-Bioantibody SARS-CoV-2 Antigen Rapid Test Kit yavunywa yi-European Union nasohlwini lwamazwe ambalwa, njenge-Bundesinstitut für Arzneimittel und Medizinprodukte, (BfArM, Germany) , MINISTÈRE DES SOLIDARITÉS: ET DE LA SANTÉ (France), I-COVID-19 In Vitro Diagnostic Devices and Test Methods Database (IVDD-TMD), njalo njalo.